>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • ARM +29.4%, CFLT +24.4%, OSCR +19.5%, BLBD +8.5%, DIS +7.6% (also to invest $1.5 bln in Epic Games; also increases dividend by 50%; announces new share repurchase program; also to make full suite of ESPN channels as standalone digital platform in fall 2025), BDC +7.5%, VKTX +7.4%, MPWR +6.4% (also acquires Axign B.V.; also increases dividend), UAA +5.7%, GL +5.3%, BTI +5.3%, WMG +5% (also launches plan to achieve $200 mln in annual savings ), CYBR +4.9%, WMS +4.7%, MAS +4.7%, QNST +4.5%, RDN +4.1%, CPA +4.1%, RRR +4.1% (also declares $1/sh special dividend), SWI +3.7%, UTI +3.4%, UL +3.4%, WYNN +3.1%, ARES +3%, PDM +2.9%, APO +2.9%, SLF +2.7%, MT +2.6%, OHI +2.5%, HAE +2.5%, EHC +2.4%, TDG +2.4%, GTES +2.4%, TPR +2.2%, CSGS +2.1% (also increases dividend), BN +1.9%, ITT +1.8%, CENT +1.7%, THC +1.6%, ALL +1.5%, NFG +1.5%, COTY +1.4%, STLA +1.4% (sales update), NWSA +1.2%, BAX +1.1%, TROW +1%, TTGT +0.9%, SAVE +0.9%, PBH +0.9%, KIM +0.9%
Other news:
  • ACTG +8.8% (licensing and settlement agreements relating to its WiFi-6 patent portfolio)
  • ADVM +6.4% (announces preliminary safety and efficacy data from the ongoing LUNA Phase 2 trial in patients with wet age-related macular degeneration) DO +5.8% (announces new floater commitments)
  • IMGN +5.7% (lifting after disclosing AbbVie (ABBV) merger update; expects the closing of the transactions to occur on or about February 12 2024)
  • GTN +2.3% (issues statement relating to DIS FOX WBD stremaing service)
  • SNPS +2.3% (mulling selling its software business according to Bloomberg)
  • FUBO +2.1% (issues statement regarding Sports Streaming JV)
  • IONS +1.9% (FDA has granted Fast Track designation to Ionis and AstraZeneca's (AZN) eplontersen)
  • SF +1.7% (raises cash dividend by 17% to $0.42 per share)
  • OMAB +1.4% (Jan traffic)
  • ALK +1.1% (ALK and HA receive second request from DOJ)
Analyst comments:
  • CRTO +3.4% (upgraded to Overweight from Equal Weight at Wells Fargo)
  • OHI +2.5% (upgraded to Neutral from Underperform at Exane BNP Paribas)
  • SPR +2% (upgraded to Outperform from Market Perform at TD Cowen)
  • ALLY +1.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
  • DFS +0.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley)